End of life care measures - Nursing Case Study

Pathophysiology

• Primary mechanism: Decreased physiological reserve—As patients approach the end of life, their organs lose the ability to sustain normal function due to accumulated chronic diseases or acute catastrophic events, leading to multi-organ failure.

• Secondary mechanism: Altered metabolism and catabolic state—In terminal stages, the body shifts towards a catabolic state, breaking down muscle and fat for energy due to reduced nutritional intake and increased metabolic demands caused by disease processes.

• Key complication: Symptom burden—The decline in organ function and altered metabolism result in exacerbated symptoms like pain, dyspnea, and fatigue, necessitating focused symptom management to enhance quality of life during end-of-life care.

Patient Profile

Demographics:

72-year-old female, retired school teacher

History:

• Key past medical history: Chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF), type 2 diabetes

• Current medications: Lisinopril, Metformin, Furosemide, Insulin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increased difficulty in breathing and fatigue

• Key symptoms: Shortness of breath, persistent cough, increased edema in lower extremities, reduced appetite

• Vital signs: Blood pressure 100/60 mmHg, heart rate 110 bpm, respiratory rate 24 breaths per minute, oxygen saturation 88% on room air, temperature 37.2°C (99°F)

Section 1

As the healthcare team continues to monitor the 72-year-old female patient, her condition demonstrates a change in status. Despite ongoing interventions to manage her symptoms, including supplemental oxygen therapy to address her hypoxia, her oxygen saturation levels remain persistently low, now averaging 85% even with increased oxygen flow. This has been accompanied by a further increase in respiratory rate to 28 breaths per minute, suggesting that her respiratory distress is escalating. Her heart rate, previously elevated, has increased further to 120 beats per minute, indicating increased cardiac demand possibly due to worsening heart failure or hypoxemia.

Recent laboratory tests reveal a concerning elevation in her B-type natriuretic peptide (BNP) levels, now at 900 pg/mL, signifying worsening heart failure and fluid overload. Her arterial blood gas analysis shows a pH of 7.32, PaCO2 of 50 mmHg, and a PaO2 of 55 mmHg, highlighting a respiratory acidosis with hypoxemia. These findings suggest that her COPD is contributing to her respiratory insufficiency, potentially exacerbated by fluid retention due to her CHF. Additionally, her blood glucose levels have been labile, with a recent reading of 220 mg/dL, indicating poor glycemic control, which may further complicate her metabolic state.

In light of these changes, the healthcare team is prompted to revise her care plan. The focus shifts towards enhancing her comfort and managing her symptom burden more effectively. Adjustments in her diuretic therapy are considered to address fluid overload, while discussions about the goals of care, including potential transition to palliative care, become increasingly pertinent. The team explores non-invasive ventilation options to improve her respiratory function and discusses with the patient and her family the possible need for more intensive interventions, ensuring her preferences and quality of life remain central to decision-making. This reflects the importance of integrating clinical reasoning with compassionate communication in end-of-life care planning.

Section 2

As the healthcare team continues to monitor the patient, her condition shows further signs of deterioration, manifesting as new complications that require immediate attention. Despite adjustments to her diuretic regimen aimed at reducing fluid overload, the patient begins to exhibit signs of acute renal impairment. Her latest laboratory results reveal a serum creatinine level of 2.5 mg/dL, up from a baseline of 1.2 mg/dL, indicating decreased kidney function, likely exacerbated by both the diuretic therapy and underlying heart failure. This renal insufficiency demands a reevaluation of her medication management, balancing the need to relieve cardiac stress with the potential risk to her renal health.

Clinically, the patient appears more lethargic, with a notable decrease in her level of consciousness. Her mental status assessment finds her confused and disoriented to time and place, which raises concerns about possible hypercapnic encephalopathy due to her elevated PaCO2 levels or even a metabolic imbalance from her fluctuating glucose levels. Her skin is cool to touch, and capillary refill is delayed, suggesting impaired peripheral perfusion. These findings prompt the team to consider a more aggressive management of her respiratory insufficiency, possibly escalating to a trial of non-invasive positive pressure ventilation (NIPPV) to improve gas exchange and reduce work of breathing.

In light of these developments, the healthcare team arranges for an urgent family meeting to discuss the patient's worsening condition. They emphasize the need to revisit the goals of care, ensuring that the patient's values and wishes direct the course of treatment. This conversation includes exploring the potential transition to hospice care, where the focus would be on maximizing comfort and quality of life, rather than curative measures. The team is committed to providing not only medical expertise but also emotional support to the patient and her family during this challenging phase, reinforcing the importance of compassionate end-of-life care.

Section 3

As the healthcare team continues to manage the patient's care, a new complication arises that necessitates immediate clinical attention. Overnight, the patient develops acute shortness of breath and an increased respiratory rate of 28 breaths per minute, accompanied by a drop in oxygen saturation to 88% on room air. A repeat arterial blood gas analysis reveals a further elevation in PaCO2 to 55 mmHg, indicating worsening hypercapnia, while the pH has decreased to 7.30, signifying respiratory acidosis. These findings confirm the team's suspicion of progressive respiratory failure, likely secondary to both her underlying heart failure and now compromised renal function affecting acid-base balance.

In response to these changes, the healthcare team promptly initiates non-invasive positive pressure ventilation (NIPPV) to assist with her breathing and improve alveolar ventilation. After a few hours on NIPPV, there is a modest improvement in the patient's respiratory effort, and her oxygen saturation stabilizes at 92% with the assistance of supplemental oxygen. However, her mental status remains concerning, as she continues to exhibit confusion and disorientation, necessitating ongoing monitoring for potential neurological sequelae of her respiratory compromise.

This evolving clinical picture prompts a further reevaluation of her treatment plan. The team discusses the need to adjust her diuretic therapy to mitigate renal stress while considering the addition of bicarbonate therapy to address her acidosis. Moreover, they prepare for the possibility of escalating to invasive ventilation should her condition not improve. These decisions are made with careful consideration of the patient's prior expressed wishes, balancing aggressive interventions with her goals of care. As they continue to navigate these complexities, the team remains committed to maintaining open communication with the patient's family, ensuring that her dignity and comfort remain at the forefront of care planning.

Section 4

As the morning progresses, the healthcare team observes a further change in the patient's status. Despite the initial stabilization achieved with non-invasive positive pressure ventilation, her oxygen requirements have increased, and she now requires a higher concentration of supplemental oxygen to maintain an SpO2 of 90%. This suggests that her respiratory function may be experiencing further compromise. Concurrently, her blood pressure has dropped to 95/60 mmHg, raising concerns about her hemodynamic stability, possibly exacerbated by her heart failure and the adjustment in diuretic therapy. These changes prompt a repeat set of laboratory tests, including a complete blood count (CBC), serum electrolytes, and renal function tests, to gain a clearer picture of her current physiological state.

The new diagnostic results reveal worsening renal function, with serum creatinine levels rising to 2.5 mg/dL, indicating acute kidney injury, likely a result of her reduced cardiac output and the recent adjustments in her medication regimen. Additionally, her potassium level has dropped to 3.0 mmol/L, posing a risk for cardiac arrhythmias, particularly given her underlying heart failure. Her lactate level has also increased to 4 mmol/L, suggesting possible tissue hypoperfusion or sepsis as a new complication. These findings necessitate a comprehensive re-evaluation of her treatment strategy, focusing on optimizing her hemodynamic status, correcting electrolyte imbalances, and investigating potential sources of infection.

In light of these developments, the healthcare team decides to initiate gentle fluid resuscitation to address her low blood pressure and improve renal perfusion, while cautiously monitoring for signs of fluid overload given her heart failure. Potassium supplementation is started to correct her hypokalemia, and broad-spectrum antibiotics are administered empirically to cover potential infections. The team also consults with the patient's family to discuss the current situation and explore the patient's wishes regarding more invasive interventions, should they become necessary. Throughout this process, the focus remains on aligning medical decisions with the patient's goals of care, ensuring that her comfort and dignity are prioritized as her condition evolves.

Section 5

As the afternoon unfolds, the patient's response to the interventions initiated earlier in the day becomes apparent. Despite the cautious fluid resuscitation efforts, her blood pressure remains low, now recorded at 90/55 mmHg, indicating persistent hemodynamic instability. While there is a slight improvement in her renal perfusion, as evidenced by a marginal decrease in serum creatinine to 2.3 mg/dL, her overall condition seems to be deteriorating. The potassium supplementation has successfully raised her potassium level to 3.5 mmol/L, reducing the immediate risk of cardiac arrhythmias. However, the patient has developed a new complication: her respiratory rate has increased to 32 breaths per minute, and she exhibits increased work of breathing, suggesting further respiratory compromise.

The team conducts another assessment, noting that the patient is increasingly lethargic and less responsive to verbal stimuli, with a Glasgow Coma Scale score of 12. Her peripheral perfusion remains poor, with cool extremities and delayed capillary refill, while her heart rate has increased to 120 beats per minute. These findings suggest possible progression to septic shock, despite the initiation of broad-spectrum antibiotics. A repeat arterial blood gas (ABG) reveals worsening metabolic acidosis, with a pH of 7.28 and a base deficit of -5, further corroborating the suspicion of a systemic inflammatory response.

Faced with these developments, the healthcare team deliberates on the next steps, focusing on optimizing her hemodynamic support and reassessing her goals of care. The possibility of initiating vasopressor support is considered to stabilize her blood pressure, but the team remains mindful of the patient's frail condition and the potential burden of aggressive interventions. They decide to engage in a thorough discussion with the patient's family, revisiting her advance directives to ensure that any further medical actions align with her values and end-of-life preferences. The team's priority remains to provide compassionate care that upholds the patient's dignity, while carefully monitoring her physiological status to guide ongoing clinical decisions.